1. The PPARα pathway in Vγ9Vδ2 T cell anergy.
- Author
-
Poupot, Mary, Boissard, Frédéric, Betous, Delphine, Bardouillet, Laure, Fruchon, Séverine, L'Faqihi-Olive, Fatima, Pont, Frédéric, Mekaouche, Mourad, Ingoure, Sophie, Sicard, Hélène, Dubreuilh, Guy, and Fournié, Jean-Jacques
- Abstract
Phosphoantigens (PAgs) activate Vγ9Vδ2 T lymphocytes, inducing their potent and rapid response in vitro and in vivo. However, humans and nonhuman primates that receive repeated injections of PAgs progressively lose their Vγ9Vδ2 T cell response to them. To elucidate the molecular mechanisms of this in vivo desensitization, we analyzed the transcriptome of circulating Vγ9Vδ2 T cells from macaques injected with PAg. We showed that three PAg injections induced the activation of the PPARα pathway in Vγ9Vδ2 T cells. Thus, we analyzed the in vitro response of Vγ9Vδ2 T cells stimulated with a PPARα agonist. We demonstrated that in vitro PPARα pathway activation led to the inhibition of the BrHPP-induced activation and proliferation of human Vγ9Vδ2 T cells. Since the PPARα pathway is involved in the antigen-selective desensitization of human Vγ9Vδ2 T cells, the use of PPARα inhibitors could enhance cancer immunotherapy based on Vγ9Vδ2 T cells. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF